skip navigation


Register for Latest Research

Stay Informed
Register with NCJRS to receive NCJRS's biweekly e-newsletter JUSTINFO and additional periodic emails from NCJRS and the NCJRS federal sponsors that highlight the latest research published or sponsored by the Office of Justice Programs.

NCJRS Abstract

The document referenced below is part of the NCJRS Virtual Library collection. To conduct further searches of the collection, visit the Virtual Library. See the Obtain Documents page for direction on how to access resources online, via mail, through interlibrary loans, or in a local library.


NCJ Number: 201736 Add to Shopping cart Find in a Library
Title: Marijuana and Medicine: Assessing the Science Base, Executive Summary
Corporate Author: National Academies Press
United States of America
Editor(s): Janet E. Joy; Stanley J. Watson Jr.; John A. Benson Jr.
Date Published: 1999
Page Count: 20
Sponsoring Agency: National Academies Press
Washington, DC 20001
US Executive Office of the President
Washington, DC 20500
Contract Number: DC7C02
Sale Source: National Academies Press
500 Fifth Street, N.W.
Keck 360
Washington, DC 20001
United States of America
Type: Monograph
Format: Document
Language: English
Country: United States of America
Annotation: This study assessed the uses and medical value of marijuana.
Abstract: In January 1997, the Institute of Medicine (IOM) was asked to conduct a review of the scientific evidence to assess the potential health benefits and risks of marijuana and its constituent cannabinoids. This request came as a result of State “medical marijuana” initiatives in California, Arizona, Alaska, Colorado, Nevada, Oregon, and Washington. The three focal concerns in evaluating the medical use of marijuana are the evaluation of the effects of isolated cannabinoids, the risks associated with the medical use of marijuana, and the use of smoked marijuana. Information was gathered through scientific workshops, site visits to cannabis buyers’ clubs and HIV/AIDS clinics, analysis of the relevant scientific literature, and extensive consultation with biomedical and social scientists. It was concluded that the different cannabinoid receptor types found in the body appear to play different roles in normal human physiology. Scientific data indicate the potential therapeutic value of cannabinoid drugs, primarily THC, for pain relief, control of nausea and vomiting, and appetite stimulation. Smoked marijuana is a crude THC delivery system that also delivers harmful substances. The psychological effects of cannabinoids such as anxiety reduction and sedation, which can influence medical benefits, should be evaluated in clinical trials. Studies suggest that marijuana smoke is an important risk factor in the development of respiratory disease. A distinctive marijuana withdrawal syndrome has been identified but it is mild and short-lived. The syndrome includes restlessness, irritability, mild agitation, insomnia, sleep EEG disturbance, nausea, and cramping. Data on drug use progression neither support nor refute the suggestion that medical availability would increase drug abuse. Research should continue into the physiological effects of synthetic and plant-derived cannabinoids. The individual health risks of smoking marijuana should be studied. Clinical trials of cannabinoid drugs for symptom management should be conducted, along with trials of marijuana use for medical purposes.
Main Term(s): Drug research; Medical uses of marijuana
Index Term(s): Controlled Substances; Drug analysis; Drug dependence; Marijuana; Medical evaluation; Medical research; Medicolegal considerations
To cite this abstract, use the following link:

*A link to the full-text document is provided whenever possible. For documents not available online, a link to the publisher's website is provided. Tell us how you use the NCJRS Library and Abstracts Database - send us your feedback.